Inventor

James M. Wilson

Inventor

Gladwyne, PA, US

Overview

1983–2020

Patent span

Chemistry

Primary field (CPC C)

Patents· 183 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary

C12NMicroorganisms or enzymes23%

A61KPreparations for medical, dental or toiletry purposes21%

C07KPeptides15%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%

C12YEnzymes6%

G06FElectric digital data processing2%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%

G02BOptical elements, systems or apparatus2%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%

H01GCapacitors1%

PatentTitleYear

10,792,343Compositions and methods for treating MPSI2020 10,786,568AAV mediated influenza vaccines2020 10,781,430Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency2020 10,780,182Methods and compositions for treating metastatic breast cancer and other cancers in the brain2020 10,741,278Pathogen detection and display system2020 10,722,598Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor2020 10,695,441Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor2020 10,647,998Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof2020 10,647,758Compositions comprising AAV expressing dual antibody constructs and uses thereof2020 10,626,415Method of increasing the function of an AAV vector2020 10,626,382Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency2020 10,590,435Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor2020 10,544,432Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby2020 10,526,617Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby2020 10,508,286Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby2019 10,501,757Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof2019 10,485,883Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor2019 10,406,173Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer2019 10,385,119Compositions comprising AAV expressing dual antibody constructs and uses thereof2019 10,308,958Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby2019 10,301,648Method of increasing the function of an AAV vector2019 10,301,650Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor2019 10,265,417Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor2019 10,266,846Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor2019 10,229,208Optimization of query execution2019 10,167,454Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency2019 10,155,931Scalable production method for AAV2018 10,149,873Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof2018 10,137,176Compositions and methods for treating MPSI2018 10,138,295Compositions comprising AAV expressing dual antibody constructs and uses thereof2018 10,113,182Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof2018 10,041,090Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby2018 9,890,365'Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency'2018 9,884,071'Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer'2018 9,790,472'Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby'2017 9,770,011'Veterinary composition and methods for non-surgical neutering and castration'2017 9,737,618'Adeno-associated virus (AAV) glades, sequences, vectors containing same, and uses therefor'2017 9,719,106'Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof'2017 9,677,089'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor'2017 9,617,561'Simian adenovirus 41 and uses thereof'2017 9,613,046'Parallel optimized remote synchronization of active block storage'2017 9,597,363'Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof'2017 9,592,284'Immunization regimen with E4-deleted adenovirus prime and E1-deleted adenovirus boost'2017 9,593,346'Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof'2017 9,587,250'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor'2017 9,584,662'System and method for the automatic validation of dialog run time systems'2017 D0779387'Bicycle pedal'2017 9,567,607'Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same'2017 9,493,788'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor'2016 9,382,551'Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof'2016 9,359,618'Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof'2016 9,343,231'Methods for manufacture a capacitor with three-dimensional high surface area electrodes'2016 9,315,825'Pharmacologically induced transgene ablation system'2016 9,217,159'Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof'2015 9,213,692'System and method for the automatic validation of dialog run time systems'2015 9,206,238'Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof'2015 9,198,984'Scalable production method for AAV'2015 9,163,260'Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same'2015 9,133,483'Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use'2015 8,999,678'Method of increasing the function of an AAV vector'2015 8,962,330'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor'2015 8,962,332'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor'2015 8,940,290'Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof'2015 8,906,675'Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby'2014 8,846,031'Simian adenovirus 41 and uses thereof'2014 8,834,863'Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof'2014 8,685,387'Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38'2014 8,683,437'System and method for the automatic validation of dialog run time systems'2014 8,637,255'Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same'2014 8,635,604'System and method for converting graphical call flows into finite state machines'2014 8,603,459'Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use'2013 8,524,219'Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof'2013 8,524,446'Method for detecting adeno-associated virus'2013 8,470,310'Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof'2013 8,394,386'Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations'2013 8,381,200'System and method for converting graphical call flows into finite state machines'2013 8,318,480'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor'2012 8,231,880'Simian subfamily C adenoviruses SAdV-40, -31, and -34 and uses thereof'2012 8,105,574'Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use'2012 8,076,257'High temperature ceramic dielectric composition and capacitors made from the composition'2011 7,906,111'Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor'2011 7,881,440'Method for automatic graphical profiling of a system'2011 7,860,713'Reducing time for annotating speech data to develop a dialog application'2010 7,838,277'Method for rapid screening of bacterial transformants and novel simian adenovirus proteins'2010 7,790,449'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor'2010 7,560,966'Method of testing connectivity using dual operational mode CML latch'2009 7,491,508'Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses'2009 7,412,383'Reducing time for annotating speech data to develop a dialog application'2008 7,358,787'Dual operational mode CML latch'2008 7,344,872'Method for rapid screening of bacterial transformants and novel simian adenovirus proteins'2008 7,319,002'Method for purification of viral vectors having proteins which bind sialic acid'2008 7,306,794'Methods and compositions for the treatment of defects in lipoprotein metabolism'2007 7,291,498'Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses'2007 7,282,199'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor'2007 7,247,472'Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use'2007 7,238,526'Methods and cell line useful for production of recombinant adeno-associated viruses'2007 7,235,393'Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues'2007 7,198,951'Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor'2007 7,186,552'Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same'2007 7,167,951'Intelligent controller accessed through addressable virtual space'2007 7,105,345'Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same'2006 7,056,502'Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids'2006 7,022,519'Compositions and methods for helper-free production of recombinant adeno-associated viruses'2006 6,953,690'Compositions and methods for helper-free production of recombinant adeno-associated viruses'2005 6,943,019'Methods and vector constructs useful for production of recombinant AAV'2005 6,887,463'Methods and compositions for the treatment of defects in lipoprotein metabolism'2005 6,821,512'Compositions and methods for increasing packaging and yield of recombinant adenoviruses using multiple packaging signals'2004 6,759,237'Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same'2004 6,723,673'High dielectric constant very low fired X7R ceramic capacitor, and powder for making'2004 6,496,215'Thermal scan line bow adjustment in an optical scanning system'2002 6,493,811'Intelligent controller accessed through addressable virtual space'2002 6,485,966'Compositions and methods for helper-free production of recombinant adeno-associated viruses'2002 6,482,634'Methods and vector constructs useful for production of recombinant AAV'2002 6,483,530'Cast honeycomb structure with integral damping for ROS platform'2002 6,480,515'Optically transparent, heat conductive fluid heat sink'2002 6,475,769'Methods and cell line useful for production of recombinant adeno-associated viruses'2002 6,428,988'Methods using cre-lox for production of recombinant adeno-associated viruses'2002 6,399,385'Methods for rapid PEG-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor'2002 6,399,370'Compositions and methods for use of defensin'2002 6,387,368'Hybrid adenovirus-AAV virus and methods of use thereof'2002 6,381,073'Single refractive element and segmented mirror multiple beam spacer'2002 6,372,208'Method of reducing an immune response to a recombinant virus'2002 6,372,013'Carrier material and desulfurization agent for desulfurizing iron'2002 6,365,394'Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus'2002 6,316,255'Hepatocytes transduced with a retroviral vector comprising splice sites'2001 6,287,571'Replication-defective adenovirus human type 5 recombinant as a vaccine carrier'2001 6,281,010'Adenovirus gene therapy vehicle and cell line'2001 6,274,354'Methods using cre-lox for production of recombinant adeno-associated viruses'2001 6,270,996'Recombinant adenovirus and adeno-associated virus, cell lines and methods of production and use thereof'2001 6,261,551'Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof'2001 6,258,595'Compositions and methods for helper-free production of recombinant adeno-associated viruses'2001 6,252,695'Multiple wobble correction optical elements to reduce height of raster output scanning (ROS) system'2001 6,251,677'Hybrid adenovirus-AAV virus and methods of use thereof'2001 6,251,957'Method of reducing an immune response to a recombinant virus'2001 6,224,858'Hepatocytes transduced with a retroviral vector comprising splice sites and methods of expression'2001 6,211,160'Method for tolerizing a mammalian patient to administration of gene therapy virus vectors'2001 6,203,975'Adenovirus and method of use thereof'2001 6,174,527'Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism'2001 6,083,716'Chimpanzee adenovirus vectors'2000 6,019,978'Replication-defective adenovirus human type 5 recombinant as a vaccine carrier'2000 6,001,557'Adenovirus and methods of use thereof'1999 6,001,350'Genetic modification of endothelial cells'1999 5,994,835'Thin film organic light emitting diode with edge emitter waveguide and electron injection layer'1999 5,940,113'Lensless printing system with a light bar printhead'1999 5,929,365'Solenoid selector switch shield for weapons system feeder assembly'1999 5,907,160'Thin film organic light emitting diode with edge emitter waveguide'1999 5,871,982'Hybrid adenovirus-AAV virus and methods of use thereof'1999 5,872,154'Method of reducing an immune response to a recombinant adenovirus'1999 5,866,552'Method for expressing a gene in the absence of an immune response'1999 5,856,152'Hybrid adenovirus-AAV vector and methods of use therefor'1999 5,783,165'Method of making barium titanate'1998 5,756,283'Method for improved production of recombinant adeno-associated viruses for gene therapy'1998 D0390675'Bike light'1998 5,698,202'Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier'1997 5,674,722'Genetic modification of endothelial cells'1997 5,667,766'Non-human animal model of a human airway, methods of use'1997 5,652,224'Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism'1997 5,650,871'Single element optics for passive facet tracking'1997 5,625,128'Non-human animal model of a human airway'1997 5,619,599'Remote split scan detector'1997 5,604,167'Y5V dielectric composition'1997 5,599,757'NPO dielectric ceramic compositions and capacitors made therefrom'1997 5,585,362'Adenovirus vectors for gene therapy'1996 5,580,776'Modified hepatocytes and uses therefor'1996 5,571,767'Low fire X7R dielectric compositions and capacitors made therefrom'1996 5,559,627'Optics for passive facet tracking'1996 5,549,426'Apparatus for forming several polygons together'1996 5,521,076'Modified hepatocytes and uses therefor'1996 5,517,328'Wobble and bow correction by dual spot pixel intensity proportioning'1996 5,480,334'Nested automatically separable flying disk assembly'1996 5,460,959'Transduced fibroblasts'1995 5,455,708'Passive scan angle doubling optical system'1995 5,357,106'Sensor for detecting beam position and start of scan position'1994 5,300,909'Selector switch shield'1994 5,240,846'Gene therapy vector for cystic fibrosis'1993 5,135,824'Coaxial terminal construction for a sealed pressurized battery'1992 5,128,289'X7R dielectric ceramic composition and capacitor made therefrom'1992 4,833,846'Ground anchor system for supporting an above ground structure'1989 4,670,243'Method of precipitating metal titanate powders'1987 4,587,737'Hand punch'1986 4,562,165'Regenerating sorbents'1985 4,500,942'Temperature stable monolithic capacitors and ceramic compositions for producing same'1985 4,379,319'Monolithic ceramic capacitors and improved ternary ceramic compositions for producing same'1983

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1983–1998Patents assigned to FERRO CORP (8)· patent assignee history

1986–2018Patents assigned to WILSON JAMES M (26)· patent assignee history

1993–2001Based in Ann Arbor, MI, US· patent location history

1994–2002Patents assigned to XEROX CORP (15)· patent assignee history

1994–2002Based in Glendora, CA, US· patent location history

1996–2014Based in Gladwyne, PA, US· patent location history

1997–2020Patents assigned to UNIV PENNSYLVANIA (120)· patent assignee history

2012–2015Patents assigned to ROY SOUMITRA (9)· patent assignee history

2012–2020Based in Glen Mills, PA, US· patent location history

2017–2020Based in Philadelphia, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV PENNSYLVANIA	120	1997–2020
WILSON JAMES Mself	26	1986–2018
XEROX CORP	15	1994–2002
ROY SOUMITRA	9	2012–2015
FERRO CORP	8	1983–1998

Locations

Location	Patents	Span
Gladwyne, Pennsylvania, US	56	1996–2014
Glen Mills, Pennsylvania, US	43	2012–2020
Philadelphia, Pennsylvania, US	23	2017–2020
Glendora, California, US	15	1994–2002
Ann Arbor, MI, US	9	1993–2001